Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride
NDC 51316-015, Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride, tablet, extended release, from CVS Health Corp.
- Product NDC
- 51316-015
- Status
- Listed
- Labeler
- CVS Health Corp
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA215434
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51316-015 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FEXOFENADINE HYDROCHLORIDE60 mg/1
- PSEUDOEPHEDRINE HYDROCHLORIDE120 mg/1
Pharmacologic classes
Adrenergic alpha-Agonists [MoA]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; alpha-Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51316-015-20 | 51316001520 | 4 BLISTER PACK in 1 CARTON (51316-015-20) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
| 51316-015-30 | 51316001530 | 6 BLISTER PACK in 1 CARTON (51316-015-30) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 51316-015 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51316-015 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51316-015. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.